新辅助治疗直肠癌患者中直肠系膜脂肪的影像组学特征作为反应指标
Radiomic Features of Mesorectal Fat as Indicators of Response in Rectal Cancer Patients Undergoing Neoadjuvant Therapy.
作者信息
Treballi Francesca, Danti Ginevra, Boccioli Sofia, Paolucci Sebastiano, Busoni Simone, Calistri Linda, Miele Vittorio
机构信息
Department of Radiology, Careggi University Hospital, 50141 Florence, Italy.
Department of Health Physics, Careggi University Hospital, 50141 Florence, Italy.
出版信息
Tomography. 2025 Apr 7;11(4):44. doi: 10.3390/tomography11040044.
BACKGROUND
Rectal cancer represents a major cause of mortality in the United States. Management strategies are highly individualized, depending on patient-specific factors and tumor characteristics. The therapeutic landscape is rapidly evolving, with notable advancements in response rates to both radiotherapy and chemotherapy. For locally advanced rectal cancer (LARC, defined as up to T3-4 N+), the standard of care involves total mesorectal excision (TME) following neoadjuvant chemoradiotherapy (nCRT). Magnetic resonance imaging (MRI) has emerged as the gold standard for local tumor staging and is increasingly pivotal in post-treatment restaging.
AIM
In our study, we proposed an MRI-based radiomic model to identify characteristic features of peritumoral mesorectal fat in two patient groups: good responders and poor responders to neoadjuvant therapy. The aim was to assess the potential presence of predictive factors for favorable or unfavorable responses to neoadjuvant chemoradiotherapy, thereby optimizing treatment management and improving personalized clinical decision-making.
METHODS
We conducted a retrospective analysis of adult patients with LARC who underwent pre- and post-nCRT MRI scans. Patients were classified as good responders (Group 0) or poor responders (Group 1) based on MRI findings, including tumor volume reduction, signal intensity changes on T2-weighted and diffusion-weighted imaging (DWI), and alterations in the circumferential resection margin (CRM) and extramural vascular invasion (EMVI) status. Classification criteria were based on the established literature to ensure consistency. Key clinical and imaging parameters, such as age, TNM stage, CRM involvement, and EMVI presence, were recorded. A radiomic model was developed using the LASSO algorithm for feature selection and regularization from 107 extracted radiomic features.
RESULTS
We included 44 patients (26 males and 18 females) who, following nCRT, were categorized into Group 0 (28 patients) and Group 1 (16 patients). The pre-treatment MRI analysis identified significant features (out of 107) for each sequence based on the Mann-Whitney test and -test. The LASSO algorithm selected three features (shape_Sphericity, shape_Maximum2DDiameterSlice, and glcm_Imc2) for the construction of the radiomic logistic regression model, and ROC curves were subsequently generated for each model (AUC: 0.76).
CONCLUSIONS
We developed an MRI-based radiomic model capable of differentiating and predicting between two groups of rectal cancer patients: responders and non-responders to neoadjuvant chemoradiotherapy (nCRT). This model has the potential to identify, at an early stage, lesions with a high likelihood of requiring surgery and those that could potentially be managed with medical treatment alone.
背景
直肠癌是美国主要的死亡原因之一。治疗策略高度个体化,取决于患者的具体因素和肿瘤特征。治疗格局正在迅速演变,放疗和化疗的缓解率都有显著进展。对于局部晚期直肠癌(LARC,定义为T3 - 4 N +),标准治疗方案是在新辅助放化疗(nCRT)后进行全直肠系膜切除术(TME)。磁共振成像(MRI)已成为局部肿瘤分期的金标准,并且在治疗后再分期中越来越关键。
目的
在我们的研究中,我们提出了一种基于MRI的放射组学模型,以识别两组患者肿瘤周围直肠系膜脂肪的特征:新辅助治疗的良好反应者和不良反应者。目的是评估新辅助放化疗有利或不利反应的预测因素的潜在存在,从而优化治疗管理并改善个性化临床决策。
方法
我们对接受nCRT前后MRI扫描的成年LARC患者进行了回顾性分析。根据MRI结果,包括肿瘤体积缩小、T2加权和扩散加权成像(DWI)上的信号强度变化以及环周切缘(CRM)和壁外血管侵犯(EMVI)状态,将患者分为良好反应者(0组)或不良反应者(1组)。分类标准基于已发表的文献以确保一致性。记录关键的临床和影像参数,如年龄、TNM分期、CRM受累情况和EMVI存在情况。使用LASSO算法从107个提取的放射组学特征中进行特征选择和正则化,开发了一个放射组学模型。
结果
我们纳入了44例患者(26例男性和18例女性),在nCRT后,这些患者被分为0组(28例患者)和1组(16例患者)。治疗前的MRI分析基于Mann - Whitney检验和检验确定了每个序列的显著特征(共107个)。LASSO算法选择了三个特征(形状_球形度、形状_最大二维切片直径和灰度共生矩阵_逆差矩2)来构建放射组学逻辑回归模型,随后为每个模型生成了ROC曲线(AUC:0.76)。
结论
我们开发了一种基于MRI的放射组学模型,能够区分和预测两组直肠癌患者:新辅助放化疗(nCRT)的反应者和无反应者。该模型有可能在早期识别出极有可能需要手术的病变以及那些可能仅通过药物治疗就能处理的病变。